Global X Aging Population ETF Rating $31.73 +0.73 (+2.35%) Closing price 05/2/2025 03:54 PM EasternExtended Trading$31.72 -0.02 (-0.05%) As of 05/2/2025 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Aging Population ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.AGNG Aggregate RatingModerate Buy 2.70Holdings in AGNG have an aggregate rating of Moderate Buy based on 505 analyst ratings issued in the past year covering 31 companies (57.2% of the portfolio).AGNG Aggregate Price Target$31.73High Prediction$31.73Average Prediction$31.73Low Prediction$31.73Holdings in AGNG have an aggregate price target of $31.73 and a range of $31.73 to $31.73 covering 31 companies (57.2% of the portfolio).AGNG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Aging Population ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 31 AGNG Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.84%WELLWelltower$150.48+0.1%4.4319 of 5 stars2.85$157.46 4.6%13Earnings ReportDividend AnnouncementAnalyst DowngradeInsider TradeAnalyst RevisionPositive News4.16%BSXBoston Scientific$104.94+1.7%4.1254 of 5 stars3.04$114.52 9.1%23Analyst UpgradePositive News3.15%AMGNAmgen$281.22-0.9%4.0982 of 5 stars2.41$308.18 9.6%22Earnings ReportAnalyst ForecastPositive NewsGap Up3.11%JNJJohnson & Johnson$156.09+1.1%4.7293 of 5 stars2.63$171.82 10.1%19Analyst Revision3.08%ABBVAbbVie$198.62+2.7%4.6181 of 5 stars2.89$211.41 6.4%27Earnings ReportAnalyst ForecastAnalyst Revision3.02%BMYBristol-Myers Squibb$50.56+1.9%4.6512 of 5 stars2.32$58.00 14.7%22Insider TradeAnalyst Revision3.02%MDTMedtronic$84.74+1.4%4.5722 of 5 stars2.44$96.14 13.5%16Positive News3.01%SYKStryker$378.60+1.2%4.8427 of 5 stars2.79$426.53 12.7%19Earnings ReportAnalyst ForecastNews CoveragePositive NewsHigh Trading Volume2.91%LLYEli Lilly and Company$825.10+3.9%4.9444 of 5 stars2.81$1,002.80 21.5%21Earnings ReportAnalyst ForecastNews CoverageGap Up2.90%AZNAstraZeneca$72.44+2.7%2.9082 of 5 stars3.10$88.00 21.5%10Earnings ReportShort Interest ↓Analyst Revision2.47%VTRVentas$66.51+1.5%4.0149 of 5 stars2.92$72.90 9.6%12Earnings ReportShort Interest ↑News CoveragePositive News2.34%EWEdwards Lifesciences$75.57+0.5%4.632 of 5 stars2.42$79.45 5.1%24Short Interest ↓Positive News1.98%ONCBeigene$255.77+0.1%1.9905 of 5 stars3.00$318.88 24.7%6Analyst RevisionNews Coverage1.80%ZBHZimmer Biomet$102.08+0.3%4.7608 of 5 stars2.32$124.15 21.6%22Upcoming EarningsPositive News1.79%REGNRegeneron Pharmaceuticals$605.61+2.6%4.8427 of 5 stars2.88$892.60 47.4%26Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionHigh Trading Volume1.59%PODDInsulet$257.01+2.7%4.5096 of 5 stars2.76$293.94 14.4%17Upcoming EarningsAnalyst DowngradeNews Coverage1.47%DXCMDexCom$81.62+16.2%4.6768 of 5 stars2.95$99.22 21.6%20Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap UpHigh Trading Volume1.22%UTHRUnited Therapeutics$294.60+0.3%4.9879 of 5 stars2.67$392.00 33.1%12Earnings ReportAnalyst ForecastInsider TradePositive News1.17%INCYIncyte$62.53+0.8%4.7928 of 5 stars2.17$73.53 17.6%18Earnings ReportAnalyst ForecastAnalyst Revision1.12%DVADaVita$140.91+0.3%4.3026 of 5 stars2.00$166.33 18.0%6Positive News0.99%EXELExelixis$39.60+1.8%4.0047 of 5 stars2.47$37.59 -5.1%19Short Interest ↑Analyst RevisionPositive News0.90%NBIXNeurocrine Biosciences$109.68+2.9%4.8868 of 5 stars2.86$160.90 46.7%22Upcoming Earnings0.85%OHIOmega Healthcare Investors$37.13-3.7%4.0809 of 5 stars2.33$42.00 13.1%9Earnings ReportShort Interest ↓News CoveragePositive NewsGap DownHigh Trading Volume0.69%EXASExact Sciences$51.55+9.3%4.5187 of 5 stars2.95$70.90 37.5%22Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap UpHigh Trading Volume0.68%HALOHalozyme Therapeutics$61.19+1.9%4.0299 of 5 stars2.60$62.89 2.8%10Upcoming EarningsAnalyst Revision0.66%ENSGThe Ensign Group$132.32+3.3%4.6968 of 5 stars2.83$163.50 23.6%6Earnings ReportAnalyst ForecastNews Coverage0.55%TFXTeleflex$126.30+0.3%4.8007 of 5 stars2.09$167.25 32.4%11Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews CoverageGap Up0.48%MMSIMerit Medical Systems$95.66+2.6%3.9936 of 5 stars3.00$107.78 12.7%10Short Interest ↑0.45%BPMCBlueprint Medicines$104.64+5.4%1.786 of 5 stars2.76$127.22 21.6%21Earnings ReportAnalyst ForecastNews CoveragePositive News0.40%GKOSGlaukos$87.60+4.9%4.7558 of 5 stars2.77$137.62 57.1%13Earnings ReportAnalyst ForecastNews CoverageHigh Trading Volume0.39%SBRASabra Health Care REIT$17.42-1.1%2.5064 of 5 stars2.71$19.33 11.0%7Upcoming EarningsPositive News This page (NASDAQ:AGNG) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Aging Population ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Aging Population ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.